Momordicin II

3,7-dihydroxy-4,4,13,14-tetramethyl-17-[6-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde

WCYLDCDQWJYEPO-UHFFFAOYSA-N CHEBI:172129 0 Reactome links 2 studies

Metabolite details

Identifier: WCYLDCDQWJYEPO-UHFFFAOYSA-N
InChI Key: WCYLDCDQWJYEPO-UHFFFAOYSA-N
IUPAC name: 3,7-dihydroxy-4,4,13,14-tetramethyl-17-[6-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde
Preferred name: Momordicin II
INN name: —
Synonym: —
ChEBI: CHEBI:172129

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China

Observed in differential profiles

G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
2:00 AM_Membrane_vs_2:00 AM_Net